Drug Type Chemical drugs |
Synonyms- |
Target |
Action antagonists |
Mechanism GPR68 antagonists(G protein-coupled receptor 68 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colonic Cancer | Preclinical | United States | 30 Apr 2025 | |
| Colonic Cancer | Preclinical | United Kingdom | 30 Apr 2025 | |
| Glioblastoma | Preclinical | United States | 29 Apr 2025 | |
| Glioblastoma | Preclinical | United Kingdom | 29 Apr 2025 |





